As NAND shortages drive requoted prices up 2-3x, VDURA’s mixed fleet architecture delivers superior performance and capacity at half the cost MILPITAS, Calif.–(As NAND shortages drive requoted prices up 2-3x, VDURA’s mixed fleet architecture delivers superior performance and capacity at half the cost MILPITAS, Calif.–(

VDURA Launches Flash Relief Program: Beat Any Vast or Weka Configuration by 50%

2026/01/28 22:03
4 min read

As NAND shortages drive requoted prices up 2-3x, VDURA’s mixed fleet architecture delivers superior performance and capacity at half the cost

MILPITAS, Calif.–(BUSINESS WIRE)–The flash supply crisis has reached a breaking point. Between Q2 2025 and Q1 2026, 30TB SSD pricing surged 257%—from $3,062 to $10,950—while HDD pricing rose just 35%. At CES 2026, Vast Data called this the “worst storage rut in 40+ years” with a 200 exabyte deficit, 52-week lead times, and price increases exceeding 50%.

Customers and resellers report stalled deals and requotes 2-3x above original pricing. All-flash vendors locked into single-commodity architectures face severe allocation constraints with no relief in sight.

To help customers navigate this crisis, VDURA today announced the Flash Relief Program: Submit any valid Vast or Weka configuration or any other all-flash high performance file systems alternative, and VDURA will beat the price by 50% while delivering superior throughput and capacity.

Why Architecture Matters Now: VDURA HYDRA

A 25PB deployment delivering 1,000 GB/s performance shows the divergence:

  • All-flash architecture: $8.50M (Q2 2025) → $24.54M (Q1 2026)
  • VDURA mixed fleet (20% SSD/80% HDD): $6.56M (Q1 2026)

VDURA is the only vendor delivering HYDRA: a modern software-defined, high-performance parallel file system with true linear scaling, native mixed-fleet SSD/HDD support, end to end performance and intelligent tiering, engineered for sustained flash-velocity reads/writes, maximum GPU saturation, operational reliability for strict SLAs, and superior economics for providers in today’s AI infrastructure race. Additionally, the ratio of flash to HDD can also seamlessly change over time with online dynamic cluster expansion, delivering both immediate cost savings and the flexibility to adapt as workloads or the underlying device commodities economics change over time.

“This flash crisis is exactly what ‘flash-only’ vendors have already acknowledged as a severe rut where they are forcing hard decisions on customers,” said Ken Claffey, CEO of VDURA.

“Several years ago, we had the foresight to pioneer the only modern high performance data storage infrastructure that isn’t chained to a single storage commodity. By intelligently utilizing all types of storage media in a true mixed-fleet architecture, we overcame the end-to-end performance bottlenecks and operational complexity that plague legacy tiered systems. Today’s market volatility is now proving us right: our customers and partners are uniquely positioned to achieve high-performance, GPU-saturating infrastructure at dramatically lower cost and with far greater supply chain resiliency than rigid all-flash alternatives can deliver. That’s why our new Flash Relief Program challenges any all-flash config: submit yours, and we’ll beat the price by 50% while matching or exceeding your specs – proving mixed-fleet isn’t just smarter, it’s immediately accessible relief.”

The Program:

Submit a Vast or Weka configuration requirements (or any other all-flash high-performance file system alternative) and VDURA will provide a competing proposal within 24 hours that:

  • Matches or exceeds performance specifications
  • Matches or exceeds capacity requirements (useable and effective)
  • Undercuts total cost by 50%

VDURA Technical Advantages:

  • Exceeds NVIDIA and AMD GPU guidelines for storage performance
  • Up to 60 GB/s reads, 40 GB/s writes throughput per flash node
  • True software-defined storage (SDS): Not tied to proprietary hardware like legacy hybrid architectures, our software runs on a multi-vendor ecosystem for adaptability, hardware availability and no vendor lock-in
  • Resilient and efficient File level Network erasure coding with inline data reduction for even greater mixed fleet effective capacity
  • Unified namespace with single data and control plane for management simplicity
  • Online Software Upgrades
  • Linear scalability without performance degradation

Valid configurations must include performance requirements (throughput, IOPS, latency), capacity requirements (raw, usable, effective), and configuration details. Submit to VDURA Flash Relief Program or email sales@vdura.com.

*For Flash Relief Program Offer and terms and conditions; visit https://www.vdura.com/flash-relief-program/.

Storage Economics & Flash Volatility Index

On January 20, VDURA released its free interactive tool that tracks quarterly flash pricing, models cost scenarios across architectures and visualizes performance-capacity-cost trade-offs. The calculator shows how all-flash economics compare to mixed fleet configurations at various SSD percentages using real market data.

Interactive calculator available at https://www.vdura.com/flash-volatility-index-and-storage-economics-optimizer-tool/.

About VDURA

VDURA provides high-performance mixed fleet storage solutions for AI/ML training, media and entertainment production, high-performance computing, and large-scale data analytics. The company’s unique HYDRA architecture enables organizations to optimize storage configurations based on workload requirements and market conditions. For more information, visit www.vdura.com.

The Storage Economics & Flash Volatility Index uses publicly available market data and uniform commodity pricing methodology for architectural comparison. Contact vendors directly for formal quotations.

Contacts

Press Contact:
Emily Gallagher
PRSENSE
emily@prsense.global
512-571-9020

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26